| Source HCPCS Code |
|
Target NDC Code |
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
00093-7704-56
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
00378-1930-93
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
00904-7172-07
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
16714-0534-01
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
31722-0560-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
33342-0106-07
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
42291-0439-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
10/31/2025 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
42291-0980-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE FILM-COATED 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
42385-0953-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
06/11/2025 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
42543-0719-04
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (GLUTEN-FREE,FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
59651-0165-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE FILM-COATED 100 MG-150 MG
|
| Detail Information |
| Relationship Start Date |
05/15/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
59651-0166-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE FILM-COATED 133 MG-200 MG
|
| Detail Information |
| Relationship Start Date |
05/15/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
59651-0167-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE FILM-COATED 167 MG-250 MG
|
| Detail Information |
| Relationship Start Date |
05/15/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
61958-0703-01
TRUVADA (FILM-COATED) 100 MG-150 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
61958-0704-01
TRUVADA (FILM-COATED) 133 MG-200 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
61958-0705-01
TRUVADA (FILM-COATED) 167 MG-250 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
64380-0719-04
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (GLUTEN-FREE,FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
65862-0354-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
69238-2092-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 100 MG-150 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
69238-2093-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 133 MG-200 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
69238-2094-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 167 MG-250 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
69238-2095-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
70710-1364-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 100 MG-150 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
70710-1365-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 133 MG-200 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
70710-1366-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 167 MG-250 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
70710-1367-03
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
76282-0677-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
01/01/2025 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
EMTRICITABINE 200MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV)
|
⇄
|
82009-0109-30
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE (FILM-COATED) 200 MG-300 MG
|
| Detail Information |
| Relationship Start Date |
01/02/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
60687-0719-25
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
69238-2095-03
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
50090-6494-01
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
50090-7719-01
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
65862-0354-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
42291-0439-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
31722-0560-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
69097-0741-02
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
76282-0677-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
61958-0701-01
Truvada
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
61958-0703-01
Truvada
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
61958-0704-01
Truvada
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
61958-0705-01
Truvada
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
51407-0112-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
42385-0953-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
42385-0953-90
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
68180-0287-01
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
68180-0287-06
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
33342-0106-07
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
00904-7172-07
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
00378-1930-93
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
16714-0534-01
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
54868-5141-00
Truvada
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
71205-0776-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
71205-0776-60
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
71205-0776-90
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
82009-0109-30
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
42543-0719-04
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
64380-0719-04
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
00093-7704-56
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
70710-1367-03
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
70710-1367-04
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0750
Hiv prep, ftc/tdf 200/300mg
|
⇄
|
70710-1367-09
Emtricitabine/Tenofovir disoproxil fumarate
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|